Form 4: OptimizeRx Director Cathy Klema Acquires Shares Through Restricted Stock Units

Director Cathy Klema acquired 6,643 shares of OptimizeRx Corp through restricted stock units, which vest on the earlier of the first anniversary of the grant date or the next annual meeting.

Summary

• Cathy Klema, a director of OptimizeRx Corp, reported a transaction on June 7, 2024, where she acquired 6,643 shares of common stock.
• The acquisition was in the form of restricted stock units (RSUs), representing a contingent right to receive shares of OptimizeRx common stock.
• These RSUs will vest on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of shareholders.
• Following the transaction, Klema beneficially owns 6,643 shares of OptimizeRx common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which can be seen as a slightly positive sign of confidence, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units is contingent upon the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to monitor the buying and selling activity of individuals with access to non-public information.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates